MOSCOW (Reuters) – Russia’s RDIF sovereign wealth fund said on Monday a U.S. firm had violated Russian patent rights on its Sputnik V vaccine against COVID-19.
RDIF, which actively markets Sputnik V abroad, did not disclose the name of the U.S. firm.
(Reporting by Polina Ivanova and Andrey Ostroukh; Writing by Gabrielle Tétrault-Farber; Editing by Edmund Blair)
